Literature for UK-383,367 (M12.005 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2020
1. Strom,T.B., Bjune,K. and Leren,T.P.
   Bone morphogenetic protein 1 cleaves the linker region between ligand-binding repeats 4 and 5 of the LDL receptor and makes the LDL receptor non-functional
   Hum Mol Genet29, 1229-1238. PubMed  Europe PubMed DOI  I
2018
2. Talantikite,M., Lecorche,P., Beau,F., Damour,O., Becker-Pauly,C., Ho,W.B., Dive,V., Vadon-Le Goff,S. and Moali,C.
   Inhibitors of BMP-1/tolloid-like proteinases: efficacy, selectivity and cellular toxicity
   FEBS Open Bio8, 2011-2021. PubMed  Europe PubMed DOI  I
2008
3. Bailey,S., Fish,P.V., Billotte,S., Bordner,J., Greiling,D., James,K., McElroy,A., Mills,J.E., Reed,C. and Webster,R.
   Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents
   Bioorg Med Chem Lett18, 6562-6567. PubMed  Europe PubMed DOI  I
2006
4. Allan,G.A., Gedge,J.I., Nedderman,A.N., Roffey,S.J., Small,H.F. and Webster,R.
   Pharmacokinetics and metabolism of UK-383,367 in rats and dogs: a rationale for long-lived plasma radioactivity
   Xenobiotica36, 399-418. PubMed  Europe PubMed DOI  I